The clinical observation of relapsed or refractory acute myeloid leukemia in patients with high CD117 expression but no FLT3-ITD mutation treated with sorafenib alone
XU Jian-hui 1, LIU Xiao-shu2 , ZHONG Yu-xia1 , HE Ying-zhi 1 , DU Jing-wen1 , HUANG Yu-xian1 , LI Yu-hua1
1 Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China; 2 Department of Hematology, Guangzhou Panyu Central Hospital
XU Jian-hui 1, LIU Xiao-shu2,ZHONG Yu-xia1,HE Ying-zhi 1,DU Jing-wen1,HUANG Yu-xian1,LI Yu-hua1. The clinical observation of relapsed or refractory acute myeloid leukemia in patients with high CD117 expression but no FLT3-ITD mutation treated with sorafenib alone[J]. Tianjin Med J, 2018, 46(8): 819-823.